Diabetes decisions — 2025

The Board granted service connection for coronary artery disease (CAD) and diabetes mellitus type II, finding that the Veteran's CAD is secondary to his now-service-connected diabetes and that his obesity, which was aggravated by other service-connected conditions, resulted in his diabetes.

The Board granted the restoration of a 100 percent rating for prostate cancer effective April 1, 2022, and denied service connection for diabetes mellitus, type II. The claims for service connection for major depressive disorder and peripheral neuropathy of the bilateral lower extremities were remanded.

The Board granted service connection for hypertension, diabetes mellitus, type II (DM), residuals of a stroke, and atherosclerotic heart disease, arteriosclerotic heart disease (coronary artery disease (CAD)), heart block, and coronary artery bypass graft (CABG) based on the evidence showing that these conditions are related to the Veteran's military service.

The Board denied service connection for type II diabetes and denied increased ratings for various disabilities, including degenerative joint disease of the lumbar spine, radiculopathy, hiatal hernia with GERD, status post bilateral inguinal hernia repair, bilateral hearing loss, and other specified trauma and stressor related disorder.

The Board denied the Veteran's claims for service connection for diabetes mellitus, type 2 and a heart disorder, both claimed as due to herbicide agent exposure.

The Board dismissed the veteran's appeal for service connection for heart disability, prostate cancer, diabetes mellitus, type II, and peripheral neuropathy due to a lack of jurisdiction.

The appeal was dismissed due to the Veteran's death during its pendency.

The Board granted an effective date of July 2, 2019, for the grant of service connection for hypertension and a rating of 10 percent for hypertension. Other claims were denied.

The Board denied earlier effective dates for the grants of service connection for prostate cancer, DM2, and ED as well as the award of SMC under 38 U.S.C. § 1114(k) because no earlier claim was filed within one year of the enactment of the PACT Act.

The Board denied the veteran's claims for increased ratings for ischemic heart disease, chronic kidney disease, and diabetes mellitus type II.

The Board granted service connection for diabetes mellitus, type II and denied a compensable disability rating for hypertension.

The Board denied service connection for chronic fatigue syndrome, left great toenail condition, diabetes mellitus due to anthrax vaccine, fibromyalgia, and right and left knee bursitis.

The Board denied service connection for a respiratory condition due to the lack of evidence supporting a current diagnosis. The issues regarding diabetes and hypertension were remanded for further development.

The Board granted service connection for multiple conditions, including spondylolisthesis or segmental instability (DJD spondylolisthesis L-5 S1), radiculopathy of the sciatic nerve, paralysis of the ulnar nerve, acromioclavicular joint arthritis, left ankle tendonitis, right knee patellofemoral syndrome, left knee patellofemoral syndrome, bilateral feet with plantar fasciitis, fibromyalgia, pituitary macroadenoma, diabetes mellitus type II, and renal failure.

The Board remands the claims for service connection for type II diabetes mellitus and obstructive sleep apnea (OSA) to obtain additional medical opinions regarding whether these conditions are aggravated by a service-connected disability.

The Board granted service connection for valvular heart disease and denied service connection for diabetes mellitus, to include blood sugar intolerance.

The appeal is dismissed due to the death of the Appellant, who was substituted to continue his appeal.

The Board remands the claim for service connection for diabetes mellitus to ensure a thorough and accurate medical examination is conducted.

The Board denied increased ratings for diabetes mellitus and peripheral neuropathy, but granted separate 10 percent disability ratings for left and right lower extremity femoral nerve peripheral neuropathy.

The Board granted an initial 10 percent rating for the Veteran's service-connected tension headaches, finding that his symptoms nearly approximate a 10 percent rating. The remaining claims were remanded.